Bryologyx
Dr. Volberding has been a leading HIV/AIDS clinician and clinical researcher leader for 30+ years. He has led many HIV research and global health initiatives. He serves as Director of the amfAR Institute for HIV Cure; and as a Member of the National Academy of Medicine.
This person is not in the org chart
This person is not in any offices
Bryologyx
BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.